British patients test world’s first personalised MRNA cancer jab for melanoma
by Athena Stavrou
Apr 26, 2024
3 minutes
The world’s first personalised mRNA cancer jab for melanoma – which also has the potential to stop lung, bladder and kidney cancer – is being tested in British patients.
The “gamechanger” jab works by telling the body to hunt down cancer cells to prevent the deadly disease from coming back and is custom-built for each person in just a few weeks.
A stage 2 trial of the jab, involving pharmaceutical firms Moderna and MSD, found it dramatically reduced the risk of the cancer returning in melanoma patients.
Now a final
You’re reading a preview, subscribe to read more.
Start your free 30 days